Real-World Evidence Opportunities for Emerging Biotech
The use of real-world evidence has greatly expanded in recent years but is still underutilized by emerging biotechs.
KAB Surveys: Establishing a Threshold of Demonstrated Understanding
Learn more about how to utilize Knowledge, Attitude, and Behavior Surveys to evaluate stakeholders in your REMS program.
A Focus on Pharmacies to Optimize Your Copay Program
With recent changes for pharmacists and pharmacies, it is beneficial for patient access to invest in relationships with these partners.
Harness the Power of Data to Enhance Your Patient Support Program
There are numerous insights to unlock within your patient services program data – but do you know where and how to look?
Compliance with Post-Marketing Requirements is Critical to the Success of Your Therapeutic
Read about the implications of the July 2023 guidance from the FDA.
Considerations for Tech Enhancements to Your Hub
Learn the optimal approach for considering technology enhancements to your existing patient services program.
The Role of Real-World Evidence in the Adoption of Biosimilars
As the US biosimilar market expands rapidly, discover why real-world evidence can unlock your market access.
Bringing the Clinical Study to the Patient
UBC & THREAD are bringing central site models to life for more diverse, inclusive, powerful observational research.
Maximizing the Potential of Hub Programs: Key Factors for Success and Future Trends
Read about strategies for hub success and anticipate upcoming trends to drive better patient outcomes through patient services.
How Well Is Your Copay Program Performing?
Find out if you are missing valuable insights from your affordability program data from UBC’s Executive Director of Analytics Lori.
